Dergiler / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 6

Investigation of syphilis coinfection and performance of the Architect Syphilis Tp ELISA screening test in HIV positive patients

Sayfa
1129–1134
Yayın Tarihi
2018-12-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Implementation of syphilis and HIV screening tests together among risk groups is considered to be appropriate.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Limited data on syphilis coinfection in human immunodeficiency virus (HIV) positive cases exist in Turkey.
📊
Temel Bulgular & Veri:Materials and methods: Totally 519 HIV positive patients were included in the study.
💡
Sonuç & Katkı:Conclusion: Implementation of syphilis and HIV screening tests together among risk groups is considered to be appropriate.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Syphilis · HIV/AIDS · coinfection

Abstract

Background/aim: Limited data on syphilis coinfection in human immunodeficiency virus (HIV) positive cases exist in Turkey. Our aim is to investigate syphilis coinfection and to evaluate the compatibility of the screening Architect Syphilis Tp ELISA with the fluorescent treponemal antibody absorption (FTA-abs) confirmation test in HIV positive cases. Materials and methods: Totally 519 HIV positive patients were included in the study. Enzyme linked fluorescent assay (ELFA) was used as a screening test and positive samples were confirmed by line immunassay (LIA). In order to discriminate acute HIV infection and false ELISA positivity, HIV-1 RNA PCR was performed in ELFA positive and LIA negative samples. Architect Syphilis TP ELISA was used for the detection of total antibodies against Treponema pallidum in HIV positive patients. Positive results were confirmed by the FTA-abs test. Results: Out of 519 HIV-1 positive patients, IgG and IgM positivity, and only IgG positivity was detected as 1.9% and 11.4% in all the samples, respectively. A total of 79 (15.2%) sera were positive with Architect Syphilis Tp ELISA test and 69 (13.3%) were positive with FTA-abs test. Statistically significant, almost perfect agreement was found between Architect Syphilis Tp ELISA and FTA-abs tests (kappa = 0.921 and P < 0.001). Conclusion: Implementation of syphilis and HIV screening tests together among risk groups is considered to be appropriate.

🔖

Bu Makaleye Atıf Yap

SÖNMEZ, C., DEMİR, T., SEZEN, F., KILIÇ, S. (2018). Investigation of syphilis coinfection and performance of the Architect Syphilis Tp ELISA screening test in HIV positive patients. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 6, 1129–1134. https://ajindex.com/articles/113837

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Bhattar S, Aggarwal P, Sahani SK, Bhalla P. Co-infections and sero-prevalence of HIV, syphilis, hepatitis B and C infections in sexually transmitted infections clinic attendees of tertiary care hospital in North India. J Res Health Sci 2016; 16: 162-165.
  2. Niama RF, Loukabou Bongolo NC, Bayonne Kombo ES, Yengo R, Mayengue PI, Mandingha Kosso EB, Louzolo I, Macosso L, Dzeret G, Dzabatou Babeaux ASP et al. Syphilis and HIV infections among pregnant women attending antenatal clinics in Republic of Congo. Pan Afr Med J 2017; 28: 8. Badie Yavari Z, Esmaeeli S, Paydary K, Emamzadeh-Fard S, Seyedalinaghi S, Rasoulinejad M. Prevalence survey of infection with Treponema pallidum among HIV-positive patients in Tehran. Asian Pac J Trop Biomed 2013; 3: 334-336.
  3. McCoy SI, Eron JJ, Kuruc JD, Strauss RP, Macdonald PD, Fiscus SA, Barnhart J, Pilcher CD, Leone PA, Miller WC. Sexually transmitted infections among patients with acute HIV in North Carolina. Sex Transm Dis 2009; 36: 372-374.
  4. Aktaş G, Ağaçfidan A, Yılmaz G, Badur S. Seroprevalence of HIV infection in patients with positive syphilis serology. İstanbul Tıp Fakültesi Dergisi 2008; 4: 116-119. Funnyé A, Akhtar A. Syphilis and human immunodeficiency virus co-infection. J Natl Med Assoc 2003; 95: 363-382. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2006; 55: 1-94. Centers for Disease Control and Prevention, Association of Public Health Laboratories. Laboratory Testing for the Diagnosis of HIV infection: Updated Recommendations. Atlanta, GA, USA: CDC; 2014.
  5. Sharma S, Chaudhary J, Hans C. VDRL v/s TPHA for diagnosis of syphilis among HIV sero-reactive patients in a tertiary care hospital. Int J Curr Microbiol App Sci 2014; 3: 726-730.
  6. Augenbraun M, French A, Glesby M, Sanchez-Keeland L, Young M, Greenblatt R, Sharma A. Hepatitis C virus infection and biological false-positive syphilis tests. Sex Transm Infect 2010; 86: 97-98.
  7. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Mcrobiol Rev 1995; 8: 1-21. Löwhagen GB. Syphilis: test procedures and therapeutic strategies. Semin Dermatol 1990; 9: 152-159.
  8. Binnicker MJ, Jespersen DJ, Rollins LO. Treponema-specific tests for serodiagnosis of syphilis: comparative evaluation of seven assays. J Clin Microbiol 2011; 49: 1313-1317.
  9. Pennap GR, Osita SO, Adoga MP. Owuna G, Agwale S. Prevalence of Treponema pallidum infection among human im